| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 153.819 | 198.730 | 170.383 | 221.171 | 262.979 | 355.277 | 615.467 | 909.587 | 941.728 | 1.089.847 |
| Total Income - EUR | 157.944 | 206.251 | 170.462 | 221.183 | 263.727 | 357.500 | 631.069 | 980.884 | 956.147 | 1.113.282 |
| Total Expenses - EUR | 159.557 | 203.377 | 183.772 | 196.439 | 236.786 | 329.034 | 576.652 | 824.041 | 873.636 | 986.772 |
| Gross Profit/Loss - EUR | -1.612 | 2.875 | -13.310 | 24.744 | 26.941 | 28.466 | 54.417 | 156.843 | 82.511 | 126.510 |
| Net Profit/Loss - EUR | -2.592 | 1.093 | -19.611 | 22.532 | 24.304 | 25.281 | 49.481 | 149.029 | 73.970 | 112.008 |
| Employees | 1 | 5 | 5 | 6 | 6 | 10 | 13 | 15 | 15 | 22 |
Check the financial reports for the company - Intercardiodiab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 88.360 | 118.182 | 96.354 | 80.032 | 124.933 | 256.730 | 300.667 | 236.523 | 236.340 | 304.787 |
| Current Assets | 9.646 | 21.861 | 13.921 | 20.756 | 34.911 | 45.199 | 90.608 | -33.206 | 137.438 | 162.689 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 2.519 | 0 | 0 | 1.551 | 1.125 |
| Receivables | 1.151 | 11.108 | 4.807 | 8.791 | 9.307 | 6.724 | 13.222 | -133.277 | 30.980 | 5.401 |
| Cash | 8.495 | 10.752 | 9.114 | 11.966 | 25.604 | 35.956 | 77.386 | 100.072 | 104.907 | 156.163 |
| Shareholders Funds | 27.828 | 28.638 | 8.543 | 30.918 | 53.202 | 77.474 | 122.774 | 149.071 | 172.474 | 245.917 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 70.298 | 117.288 | 101.732 | 69.871 | 106.642 | 230.656 | 272.237 | 55.060 | 202.624 | 224.025 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Intercardiodiab Srl